← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VITRUVIAS THERAP · Approved 2017-09-25

Drug application

FDA Application #

ANDA208822

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIDOCAINE

Generic name

Lidocaine

Active ingredients

LIDOCAINE

Dosage form

OINTMENT

Route

TOPICAL

Marketing status

Discontinued

Sponsor

VITRUVIAS THERAP

First approval

2017-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown